Stephens Inc Novo Nordisk A S Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Stephens Inc holds 25,128 shares of NVO stock, worth $1.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,128

Previous 150,409 83.29%

Holding current value

$1.33 Million

Previous $10.4 Million 86.57%

% of portfolio

0.02%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$45.38 - $71.7 $5.69 Million - $8.98 Million	-125,281 Reduced 83.29%	25,128 $1.39 Million
Q2 2025 Jul 29, 2025	BUY	$58.08 - $81.05 $158,035 - $220,537	2,721 Added 1.84%	150,409 $10.4 Million
Q1 2025 May 01, 2025	BUY	$69.3 - $90.95 $3.07 Million - $4.03 Million	44,270 Added 42.81%	147,688 $10.3 Million
Q4 2024 Jan 28, 2025	SELL	$85.0 - $120.04 $4.71 Million - $6.66 Million	-55,463 Reduced 34.91%	103,418 $8.9 Million
Q3 2024 Oct 28, 2024	BUY	$119.07 - $145.42 $4.48 Million - $5.47 Million	37,585 Added 30.99%	158,881 $18.9 Million
Q2 2024 Aug 06, 2024	BUY	$122.71 - $146.91 $2.94 Million - $3.52 Million	23,934 Added 24.58%	121,296 $17.3 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $2.87 Million - $3.82 Million	28,116 Added 40.6%	97,362 $12.5 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $372,626 - $447,635	4,245 Added 6.53%	69,246 $7.16 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $2.8 Million - $6.14 Million	30,782 Added 89.96%	65,001 $5.91 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $707,057 - $782,622	-4,533 Reduced 11.7%	34,219 $5.54 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $835,594 - $1 Million	6,314 Added 19.46%	38,752 $6.17 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $65,426 - $86,340	-638 Reduced 1.93%	32,438 $4.39 Million
Q3 2022 Nov 02, 2022	BUY	$95.28 - $116.93 $137,393 - $168,613	1,442 Added 4.56%	33,076 $3.3 Million
Q2 2022 Aug 03, 2022	SELL	$103.24 - $121.81 $14,763 - $17,418	-143 Reduced 0.45%	31,634 $3.53 Million
Q1 2022 May 04, 2022	SELL	$93.1 - $112.54 $124,753 - $150,803	-1,340 Reduced 4.05%	31,777 $3.53 Million
Q4 2021 Mar 07, 2022	SELL	$95.88 - $117.08 $113,713 - $138,856	-1,186 Reduced 3.46%	33,117 $3.71 Million
Q3 2021 Oct 27, 2021	SELL	$84.42 - $106.62 $2.7 Million - $3.42 Million	-32,042 Reduced 48.3%	34,303 $3.29 Million
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $1.58 Million - $1.98 Million	23,375 Added 54.4%	66,345 $5.56 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $610,111 - $689,810	9,098 Added 26.86%	42,970 $2.9 Million
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $68,937 - $79,630	1,079 Added 3.29%	33,872 $2.37 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $15,986 - $17,625	251 Added 0.77%	32,793 $2.28 Million
Q2 2020 Aug 24, 2020	SELL	$58.54 - $67.94 $945,186 - $1.1 Million	-16,146 Reduced 33.16%	32,542 $2.13 Million
Q1 2020 May 14, 2020	BUY	$49.46 - $64.78 $54,554 - $71,452	1,103 Added 2.32%	48,688 $2.93 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $119,564 - $139,707	2,398 Added 5.31%	47,585 $2.75 Million
Q3 2019 Oct 18, 2019	BUY	$47.54 - $53.43 $64,654 - $72,664	1,360 Added 3.1%	45,187 $2.34 Million
Q2 2019 Aug 01, 2019	BUY	$46.79 - $52.47 $169,894 - $190,518	3,631 Added 9.03%	43,827 $2.24 Million
Q1 2019 May 03, 2019	BUY	$46.36 - $52.63 $174,174 - $197,730	3,757 Added 10.31%	40,196 $2.1 Million
Q4 2018 Feb 11, 2019	BUY	$41.54 - $47.25 $106,217 - $120,818	2,557 Added 7.55%	36,439 $1.68 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $1.58 Million - $1.74 Million	33,882 New	33,882 $1.6 Million
Q3 2017 Nov 08, 2017	SELL	$41.15 - $49.22 $1.84 Million - $2.2 Million	-44,643 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	44,643	44,643 $1.92 Million

Others Institutions Holding NVO

# of Institutions

1,705

Shares Held

311M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $119B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account